Aspirin reduces the risk of type 2 diabetes associated with COVID-19-Reference-Cited by-同舟云学术

Aspirin reduces the risk of type 2 diabetes associated with COVID-19

Published:2025-06-18 Issue:1 Volume:3 Page:
ISSN:2948-2828
Container-title:npj Metabolic Health and Disease
language:en
Short-container-title:npj Metab Health Dis

Author:

Trimarco Valentina,Izzo Raffaele,Pacella Daniela,Manzi Maria Virginia,Jankauskas Stanislovas S.,Gallo Paola,Rozza Francesco,Giugliano Giuseppe,Spinelli Alessandra,Esposito Giovanni,Piccinocchi Roberto,Piccinocchi Gaetano,Morisco Carmine,Lembo Maria,Santulli Gaetano,Trimarco Bruno

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s44324-025-00072-3.pdf

Reference80 articles.

1. Stiegmann, R. A., Payne, C. B., Kiel, M. A. & Stahlman, S. L. Increased prevalence of overweight and obesity and incidence of prediabetes and type 2 diabetes during the COVID-19 Pandemic, Active Component Service Members, U.S. Armed Forces, 2018 to 2021. MSMR 30, 11–18 (2023).

2. Li, J. et al. Increased risk of new-onset diabetes in patients with COVID-19: a systematic review and meta-analysis. Front. Public Health 11, 1170156 (2023).

3. Cefalu, W. T. COVID-19 and rising incidence of diabetes: despite evolving data, an enigma still to be solved. Diab. Care 46, 913–915 (2023).

4. Bellia, C. et al. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis. Front. Endocrinol. ((Lausanne)) 14, 1215879 (2023).

5. Miller, M. G., Terebuh, P., Kaelber, D. C., Xu, R. & Davis, P. B. SARS-CoV-2 Infection and New-Onset Type 2 Diabetes Among Pediatric Patients, 2020 to 2022. JAMA Netw Open. 7, e2439444 (2024).